Skip to main content
. 2023 Aug 22;43(8):1724–1739. doi: 10.1007/s10875-023-01558-9

Table 4.

Characterization of vaccinated and naive to infection individuals who respond to the post-12-month questionnaire

Characteristics All post-12-months Not infected post-12-months Infected post-12-months p-value1
Univariable Multivariable
n 169 134 35
M/F 32/137 27/107 5/30 0.6
Age (years), median (IQR) 50 (42; 57) 52 (43; 58) 44 (35; 52) 0.0026 0.0084
BMI (ratio), median (IQR) 23.5 (21.7; 27) 23.6 (21.7; 27.1) 23.3 (21.2; 26.2) 0.63
Comorbidities (n, %) 67 (39.6%) 55 (41%) 12 (34.3%) 0.6
HCWs (n, %) 38 (22.5%) 26 (19.4%) 12 (34.3%) 0.07 0.25
Time between last dose and questionnaire (days), median (IQR) 96 (75.5; 107.3) 74 (39; 130) 0.0001 0.14
Time between vaccination and sampling (days), median (IQR) 181 (144; 224) 181.5 (144; 223.3) 180 (139; 238) 0.95
Number of vaccine doses before sampling (n, %) 2 (169, 100%) 2 (134, 100%) 2 (35, 100%)
Current number of vaccine doses (n, %) 3 (126, 94%) 3 (22, 62.9%)  < 0.0001 0.28
Anti-SP IgG (BAU/mL), median (IQR) 147 (70; 320.5) 149.5 (70.8; 331) 129 (62; 259) 0.5
Neutralization of Wuhan variant, median (IQR) 3.9 (1.9; 7.9) 4.1 (2; 7.9) 3.8 (1.7; 7) 0.7
Neutralization of Alpha variant, median (IQR) 3.3 (1.5; 6) 3.4 (1.5; 6.2) 3.2 (1.5; 5.4) 0.7
Neutralization of Delta variant, median (IQR) 3.1 (1.6; 6.4) 3 (1.5; 6.5) 3.5 (1.8; 5.4) 0.9
SARS-CoV-2 specific T cell response (IU/mL), median (IQR) 0.23 (0.1; 0.53) 0.25 (0.12; 0.58) 0.15 (0.08; 0.32) 0.06 0.04

N number; IQR interquartile range; HCW health care workers; Anti-SP anti-Spike; IgG immunoglobulin G; Anti-N anti-nucleocapsid

*p < 0.05, **p < 0.005, ***p < 0.0005, ****p < 0.00005

1Mann-Whitney test for quantitative variables; Fisher’s exact test for qualitative variables. All tests are two-sided with statistical significance p < 0.05. To identify infection and bad vaccine responder’s predictive factors, all variables with p < 0.15 in unadjusted analysis were used for multivariable logistic regression models